|
Market Closed -
NYSE
04:00:03 2026-11-02 pm EST
|
5-day change | 1st Jan Change | ||
| 10.19 USD | -4.23% |
|
-0.29% | -36.43% |
| Oct. 29 | Core Laboratories Inc., Q3 2026 Earnings Call, Oct 29, 2026 | |
| Oct. 28 | Core Laboratories Inc. Provides Earnings Guidance for the Fourth Quarter of 2026 | CI |
Company Valuation: Core Laboratories Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|
| Market Cap 1 | 1,033 | 939.9 | 825.1 | 812.7 | 746.4 | 466.9 | - |
| Change | - | -8.98% | -12.21% | -1.51% | -8.16% | -37.44% | - |
| Enterprise Value (EV) | 1,204 | 1,097 | 973.2 | 919.7 | 746.4 | 466.9 | 466.9 |
| Change | - | -8.87% | -11.28% | -5.5% | -18.84% | -37.44% | 0% |
| P/E | 53.1x | 48.3x | 20.5x | 26.2x | 23.6x | 23.7x | 13.3x |
| PBR | 6.47x | 5.02x | - | - | - | - | - |
| PEG | - | - | 0x | -1.1x | 7.79x | -0.6x | 0.2x |
| Capitalization / Revenue | 2.2x | 1.92x | 1.62x | 1.55x | 1.42x | 0.91x | 0.89x |
| EV / Revenue | 0x | 0x | 0x | 0x | 0x | 0.91x | 0.89x |
| EV / EBITDA | 0x | 0x | 0x | 0x | 0x | 7.81x | 6.77x |
| EV / EBIT | 0x | 0x | 0x | 0x | 0x | 11.7x | 8.3x |
| EV / FCF | 0x | 0x | 0x | 0x | 0x | 20.8x | 9.61x |
| FCF Yield | 2.23% | 1.57% | 1.72% | 5.34% | 3.48% | 4.8% | 10.4% |
| Dividend per Share 2 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 |
| Rate of return | 0.18% | 0.2% | 0.23% | 0.23% | 0.25% | 0.39% | 0.39% |
| EPS 2 | 0.42 | 0.42 | 0.86 | 0.66 | 0.68 | 0.43 | 0.765 |
| Distribution rate | 9.52% | 9.52% | 4.65% | 6.06% | 5.88% | 9.3% | 5.23% |
| Net sales 1 | 470.3 | 489.7 | 509.8 | 523.8 | 526.5 | 511.9 | 524.8 |
| EBITDA 1 | 70.81 | 61.98 | 76.96 | 80.2 | 73.34 | 59.79 | 69 |
| EBIT 1 | 52.29 | 44.82 | 61.18 | 65.25 | 58.7 | 39.94 | 56.25 |
| Net income 1 | 19.73 | 19.45 | 40.94 | 31.4 | 31.8 | 19.87 | 35.85 |
| Net Debt | 170.9 | 157 | 148 | 107 | - | - | - |
| Reference price 2 | 22.31 | 20.27 | 17.66 | 17.31 | 16.03 | 10.19 | 10.19 |
| Nbr of stocks (in thousands) | 46,290 | 46,371 | 46,724 | 46,950 | 46,563 | 45,823 | - |
| Announcement Date | 2/2/22 | 2/1/23 | 1/31/24 | 1/29/25 | 2/4/26 | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 24.74x | - | - | 0.38% | 488M | |
| 33.01x | 17.01x | 24.19x | 0.65% | 769B | |
| 39.88x | 7.25x | 25.73x | 0.9% | 87.29B | |
| 24.18x | 4.82x | 10.5x | 0.68% | 72.45B | |
| 11.24x | 1.46x | 7.24x | 0.99% | 47.36B | |
| 44.13x | 1.69x | 9.5x | -.--% | 46.08B | |
| -72.94x | 16.71x | 40.54x | -.--% | 42.25B | |
| 21.64x | 3.6x | 8.53x | 1.48% | 34.27B | |
| 10.51x | 2.68x | 6.46x | -.--% | 26.6B | |
| 20.1x | 6.14x | 11.77x | -.--% | 26.33B | |
| Average | 15.65x | 6.82x | 16.05x | 0.51% | 115.22B | |
| Weighted average by Cap. | 27.48x | 13.26x | 21.60x | 0.63% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- CLB Stock
- Valuation Core Laboratories Inc.
Select your edition
All financial news and data tailored to specific country editions
